Apremist 30mg tablet

Apremist 30 mg tablet is a prescription drug used for treating plaque psoriasis, psoriatic arthritis, and oral ulcers caused by Behçet’s disease.

Classification of Drug: It is a PDE4 inhibitor. It is an immunomodulatory Apremist 30mg tablet IN PAKISTAN agent which means it is neither a steroid nor a biologic. Mechanism: It inhibits PDE4 enzyme within cells and reduces inflammatory markers responsible for scaling, joint swelling, and pain. Physical Appearance: It is usually supplied as a film-coated tablet (usually white to off-white) containing 30 mg of active apremilast. Brand name includes Otezla.

Maintenance Dose: One 30 mg tablet administered Apremist 30mg tablet PRICE IN PAKISTAN orally twice a day (morning and evening) with or without food. Initial Dosage Adjustment: It is started at lower doses in 5 to 6 days (progressively increased) to reduce gastrointestinal discomfort. Intake: The tablets need to be swallowed intact, never chewed, crushed, or divided.

Common Gastrointestinal Adverse Effects: They include diarrhea, nausea, vomiting, and upper abdominal pain. Other Adverse Effects: They include headache, upper respiratory tract infections, and insomnia. Contraindications: It may lead to unintentional weight loss and mood alterations such as depression and suicidal behavior. Medical supervision is necessary for patients suffering from severe kidney impairment and those with previous history of depression.